Back to Search
Start Over
Time to first disease progression, but not (beta)2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy
- Source :
- Cancer. August 15, 2007, Vol. 110 Issue 4, p824, 6 p.
- Publication Year :
- 2007
- Subjects :
- Prognosis -- Research
Outcome and process assessment (Health Care) -- Research
Thalidomide -- Dosage and administration
Beta globulins -- Physiological aspects
Multiple myeloma -- Patient outcomes
Multiple myeloma -- Development and progression
Multiple myeloma -- Diagnosis
Multiple myeloma -- Care and treatment
Health
Subjects
Details
- Language :
- English
- ISSN :
- 0008543X
- Volume :
- 110
- Issue :
- 4
- Database :
- Gale General OneFile
- Journal :
- Cancer
- Publication Type :
- Periodical
- Accession number :
- edsgcl.169396893